Abstract:Background: Autogenous bone graft is the gold standard bone grafting substrate available in spinal fusion because of its osteoconductive, osteogenic, and osteoinductive properties. However, several shortcomings including bleeding, infection, chronic pain, and nerve injury are known to be associated with the procedure. Bone tissue engineering has emerged as an alternative therapeutic strategy for bone grafts. New materials have been developed and tested that can substitute for the autogenous bone grafts used in the spinal fusion. The purpose of this study is to evaluate the role of a novel tissue-engineered bone graft with silicon-substituted calcium phosphate (Si-CaP), autogenous fine particulate bone powder (AFPBP), and bone marrow mesenchymal stem cells (BMSCs) using a rabbit posterolateral lumbar fusion model based on bone tissue engineering principles. The application of this graft can represent a novel choice for autogenous bone to reduce the amount of autogenous bone and promote spinal fusion. Methods: BMSCs from New Zealand white rabbits were isolated and cultured in vitro. Then, BMSCs were marked by the cell tracker chloromethyl-benzamidodialkylcarbocyanine (CM-Dil). A total of 96 New Zealand White rabbits were randomly divided into four groups: (a) AFPBP, (b) Si-CaP, (c) Si-CaP/AFPBP, (d) Si-CaP/AFPBP/ BMSCs.The rabbits underwent bilateral posterolateral spine arthrodesis of the L5-L6 intertransverse processes using different grafts. Spinal fusion and bone formation were evaluated at 4, 8, and 12 weeks after surgery by manual palpation, radiology, micro-computed tomography (micro-CT), histology, and scanning electronic microscopy (SEM). Results: The rate of fusion by manual palpation was higher in the Si-CaP/AFPBP/BMSCs group than the other groups at 8 weeks. The fusion rates in the Si-CaP/AFPBP/BMSCs and the AFPBP groups both reached 100%, which was higher than the Si-CaP/AFPBP group (62.5%) (P > 0.05). No difference in bone volume was observed between the Si-CaP/AFPBP/BMSCs group (44.39%) and AFPBP group (45.06%) at 12 weeks (P < 0.05). At 12 weeks, new trabecular were visible in the Si-CaP/AFPBP/BMSCs group by SEM. CM-Dil-positive cells were observed at all stages. Compared with histological images, BMSCs participate in various stages of osteogenesis by transforming into osteoblasts, chondrocytes, and osteocytes. Conclusion: This study demonstrated for the first time that Si-CaP/AFPBP/BMSCs is a novel tissue-engineered bone graft with excellent bioactivity, biocompatibility, and biodegradability. The graft could reduce the amount of autogenous bone and promote spinal fusion in a rabbit posterolateral lumbar fusion model, representing a novel alternative to autogenous bone. The Translational potential of this article: The translational potential of this article lies in that this graft will be a novel spinal fusion graft with great potential for clinical applications.

P84. Bone Marrow Aspirate with or Without Platelet Concentrates As a Bone Graft Substitute for Posterolateral Spinal Fusion: A Randomized, Controlled Study Using an Animal Model

Improved Posterolateral Lumbar Spinal Fusion Using a Biomimetic, Nanocomposite Scaffold Augmented by Autologous Platelet-Rich Plasma

Effects of a bone graft substitute consisting of porous gradient HA/ZrO 2 and gelatin/chitosan slow-release hydrogel containing BMP-2 and BMSCs on lumbar vertebral defect repair in rhesus monkey.

Clinical study of lumbar fusion by hybrid construct of stem cells technique and biodegradable material

Anterior Lumbar Interbody Fusion with Carbon Fiber Cage Loaded with Bioceramics and Platelet-Rich Plasma. an Experimental Study on Pigs

407 Results of Biphasic Calcium Phosphate Bone Graft With Submicron-Sized Needle-Shaped Surface Topography as Standalone Alternative to Autograft Are Favorable in a Prospective, Multi-center, Randomized, Intra-patient Controlled Trial

The Primary Report of Clinical Application of Enriched Bone Marrow Stem Cells Combining with Β-Tricalcium Phosphate in Spine Fusion

1074 A Prospective, Post Market, Multi-center, Open Label, Non-randomized Clinical Study of the Efficacy of Using a Cellular Bone Allograft (CBA) in Lumbar Fusion Surgery

A Novel Tissue-Engineered Bone Graft Composed of Silicon-Substituted Calcium Phosphate, Autogenous Fine Particulate Bone Powder and BMSCs Promotes Posterolateral Spinal Fusion in Rabbits

Intervertebral Spinal Fusion Using A Rp-Based Plga/Tcp/Bbmp Biomimetic Grafting Material

1078 Performance of Improved Forms of Demineralized Bone Fiber Allografts in Rabbit Posterolateral Spine Fusion Model

Lumbar Spinal Fusion with a Mineralized Collagen Matrix and Rhbmp-2 in a Rabbit Model.

Recent Research Advances in Biologic Bone Graft Materials for Spine Surgery

Bone marrow mesenchymal stem cells loaded β-tricalcium phosphate promote lumbar intervertebral fusion: a randomized controlled clinical trial

The Clinical Use of Enriched Bone Marrow Stem Cells Combined with Porous Beta-Tricalcium Phosphate in Posterior Spinal Fusion

Experimental Posterior Interlaminar Spinal Fusion in Rabbits with a New Biomimetic Grafting Material

A study on the effect of platelet-rich plasma (PRP) to promote bone fusion in lateral interbody fusion of the lumbar spine using artificial bone

Accelerated Postero-Lateral Spinal Fusion By Collagen Scaffolds Modified With Engineered Collagen-Binding Human Bone Morphogenetic Protein-2 In Rats

Bone barrow mesenchymal stem cells in conjunction with bone morphOgenetic protein promote spine interbody fusion in rabbits

Synergistic enhancement of spinal fusion in preclinical models using low-dose rhBMP-2 and stromal vascular fraction in an injectable hydrogel composite

The efficacy of platelet-rich plasma applicated in spinal fusion surgery: A meta-analysis